Immunoblastic Lymphadenopathy: Clinical Trials

4 trials for Immunoblastic Lymphadenopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Unknown 4

Follow Immunoblastic Lymphadenopathy: new trials by email Literature Review of Immunoblastic Lymphadenopathy trials Research Report on Immunoblastic Lymphadenopathy

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
ketamine hydrochloride, pharmacogenomic studies, questionnaire administration - Cancer
Phase 3UnknownUniversity of Glasgow2142009-04-012011-05-13
Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP
alemtuzumab, chemotherapy - Peripheral T Cell Lymphoma, Unspecified, Angioimmunoblastic Lymphadenopathy
Phase 3UnknownUniversity of Göttingen2742008-02-012012-05-07
Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia
amoxicillin-clavulanate potassium, ciprofloxacin, psychosocial assessment and care - Brain and Central Nervous System Tumors, Lymphoma
Phase 3UnknownClatterbridge Centre for Oncology4002007-07-012013-08-12
Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
cefepime hydrochloride, levofloxacin - Fever, Sweats, and Hot Flashes, Infection
Phase 3UnknownJonsson Comprehensive Cancer Center2001-09-012013-12-19

Narrower conditions

Burkitt Lymphoma (3)  ·  Hodgkin Disease (3)  ·  Intraocular Lymphoma (3)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (3)  ·  Lymphoma, B-Cell, Marginal Zone (3)  ·  Lymphoma, Extranodal NK-T-Cell (3)  ·  Lymphoma, Follicular (3)  ·  Lymphoma, Large B-Cell, Diffuse (3)  ·  Lymphoma, Large-Cell, Anaplastic (3)  ·  Lymphoma, Large-Cell, Immunoblastic (3)  ·  Lymphoma, Mantle-Cell (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Lymphoma, T-Cell, Cutaneous (3)  ·  Mycosis Fungoides (3)

Broader conditions

Hemic and Lymphatic Diseases (4)  ·  Immune System Diseases (4)  ·  Immunoproliferative Disorders (4)  ·  Lymphadenopathy (4)  ·  Lymphatic Diseases (4)  ·  Lymphoproliferative Disorders (4)  ·  Neoplasms by Histologic Type (4)  ·  Chronic Disease (3)  ·  DNA Virus Infections (3)  ·  Disease Attributes (3)  ·  Epstein-Barr Virus Infections (3)  ·  Eye Neoplasms (3)  ·  Hematologic Diseases (3)  ·  Herpesviridae Infections (3)  ·  Leukemia, B-Cell (3)

Interventions

Alemtuzumab (1)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Cefepime (1)  ·  Ciprofloxacin (1)  ·  Doxorubicin (1)  ·  Drug Therapy (1)  ·  Ketamine (1)  ·  Levofloxacin (1)  ·  Pharmacogenomic Testing (1)  ·  Psychiatric Rehabilitation (1)

Sponsors

Clatterbridge Centre for Oncology (1)  ·  Jonsson Comprehensive Cancer Center (1)  ·  University of Glasgow (1)  ·  University of Göttingen (1)

Countries

United Kingdom (2)  ·  Germany (1)  ·  United States (1)

Top investigators

Barry J.A. Laird, MD (1)  ·  Ernest Marshall, MD (1)  ·  Marie T. Fallon (1)  ·  Mary C. Territo, MD (1)